Gilead Sciences Inc (NASDAQ:GILD) on 05/02/2019 declared a dividend of $ 0.6300 per share payable on June 27, 2019 to shareholders of record as of June 14, 2019.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 3.8846921921% and has increased its dividends for 3 successive years.

Gilead Sciences Inc's market cap is $ 82,702,503,520 and has a PE ratio of 15.56. The stock price closed yesterday at $ 64.87 and has a 52 week low/high of $ 60.32 and $ 79.61.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. Co.'s products include Biktarvy for the treatment of HIV-1 infection in certain patients, Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease, Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, and Letairis® (ambrisentan) for the treatment of pulmonary arterial hypertension.

For more information on Gilead Sciences Inc click here.